Shandong Sito Bio-technology Co Ltd
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a me… Read more
Shandong Sito Bio-technology Co Ltd (300583) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.008x
Based on the latest financial reports, Shandong Sito Bio-technology Co Ltd (300583) has a cash flow conversion efficiency ratio of 0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.13 Million) by net assets (CN¥1.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shandong Sito Bio-technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Shandong Sito Bio-technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shandong Sito Bio-technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Sito Bio-technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dye & Durham Limited
PINK:DYNDF
|
-0.048x |
|
Beijing Integrity Technology Co. Ltd. A
SHG:688244
|
N/A |
|
KENMARE RES PLC EO-001
F:JEVA
|
N/A |
|
VOLUE ASA NK -40
F:642
|
N/A |
|
Pss Co Ltd
TW:6914
|
0.191x |
|
Chongqing Changjiang River Moulding Material (Group) Co. Ltd.
SHE:001296
|
0.038x |
|
Wistron Information Technology & Services
TWO:4953
|
0.048x |
|
RGC Resources Inc
NASDAQ:RGCO
|
0.009x |
Annual Cash Flow Conversion Efficiency for Shandong Sito Bio-technology Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Sito Bio-technology Co Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.88 Billion | CN¥194.46 Million | 0.103x | +329.60% |
| 2023-12-31 | CN¥2.07 Billion | CN¥-92.85 Million | -0.045x | -154.77% |
| 2022-12-31 | CN¥1.77 Billion | CN¥145.34 Million | 0.082x | -37.48% |
| 2021-12-31 | CN¥1.73 Billion | CN¥227.35 Million | 0.131x | -12.80% |
| 2020-12-31 | CN¥1.69 Billion | CN¥254.60 Million | 0.151x | +392.93% |
| 2019-12-31 | CN¥1.89 Billion | CN¥57.62 Million | 0.031x | +117.00% |
| 2018-12-31 | CN¥1.86 Billion | CN¥-334.41 Million | -0.180x | -2914.08% |
| 2017-12-31 | CN¥1.71 Billion | CN¥10.90 Million | 0.006x | -95.20% |
| 2016-12-31 | CN¥603.01 Million | CN¥80.15 Million | 0.133x | -22.69% |
| 2015-12-31 | CN¥506.66 Million | CN¥87.10 Million | 0.172x | -71.35% |
| 2014-12-31 | CN¥290.80 Million | CN¥174.49 Million | 0.600x | +137.69% |
| 2013-12-31 | CN¥98.83 Million | CN¥24.95 Million | 0.252x | +126.87% |
| 2012-12-31 | CN¥32.47 Million | CN¥-30.50 Million | -0.939x | -- |